[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354451-105":59,"doc-detail-354451-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","impact-of-plant-based-interventions-on-gynecological-cancers-narrative-review-of-mechanistic-interplays-and-clinical-evidence","Impact of plant-based interventions on gynecological cancers - narrative review of mechanistic interplays and clinical evidence","","Gynecological cancers impose a major global burden, particularly in low- and middle-income countries, where screening and vaccination are insufficient and conventional therapies face toxicity, chemoresistance, recurrence, and financial barriers. This narrative review synthesizes preclinical, epidemiological, and emerging clinical evidence on plant-derived phytochemicals, including alkaloids, flavonoids, terpenoids, polyphenols, coumarins, and organosulfur compounds. It highlights mechanistic effects on tumor proliferation, apoptosis, angiogenesis, oxidative stress, inflammation, hormone signaling, HPV E6/E7 oncoproteins, and epigenetic regulation, and discusses translational constraints and nanoformulation strategies.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/impact-of-plant-based-interventions-on-gynecological-cancers-narrative-review-of-mechanistic-interplays-and-clinical-evidence/354451/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/impact-of-plant-based-interventions-on-gynecological-cancers-narrative-review-of-mechanistic-interplays-and-clinical-evidence/354451.png","ImageObject",300,407,{"name":92,"@type":93},"Fans","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What major problems limit current treatment of gynecological cancers?","Question",{"text":113,"@type":114},"Surgery, platinum-based chemotherapy, and radiotherapy are constrained by systemic toxicity, acquired chemoresistance, recurrence, and poor financial accessibility in resource-limited settings. The review also notes persistent cervical cancer linked to insufficient screening and vaccination infrastructure.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which plant-derived compound classes are covered and what mechanisms do they affect?",{"text":118,"@type":114},"The review synthesizes evidence for alkaloids, flavonoids, terpenoids, polyphenols, coumarins, and organosulfur compounds. These modulate tumor proliferation, apoptosis (intrinsic and extrinsic), angiogenesis, oxidative stress, inflammation, hormone receptor signaling, HPV E6/E7 oncoprotein expression, and epigenetic regulation.",{"name":120,"@type":111,"acceptedAnswer":121},"Why is clinical translation difficult for most phytochemicals, and how might nanoformulations help?",{"text":122,"@type":114},"Most non-approved phytochemicals face poor oral bioavailability, unstandardized botanical preparations, limited randomized trial data, and incompletely characterized herb-drug interaction profiles. Nanoformulation approaches such as liposomal encapsulation, PLGA nanoparticles, and phytosomes are discussed as practical routes to overcome pharmacokinetic obstacles.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},354451,1790174415,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":31,"preview_page_count":19,"preview_urls":145},5909892330395,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","TYPE Review  \nPUBLISHED 23 June 2026  \nDOI 10.3389/fmmed.2026.1832188  \nOPEN ACCESS  \nEDITED BY  \nWenjie Lv,  \nShanghai Jiao Tong University, China  \nREVIEWED BY  \nMukul Machhindra Barwant, Sanjivani Arts, Commerce and Science College, India  \nAqsa Khan,  \nChildren’s Hospital of Philadelphia Research Institute, United States  \n*CORRESPONDENCE  \nPrecious Adeoye Oyedokun,  \n [preciousoyedokun21@gmail.com](preciousoyedokun21@gmail.com),  \n oyedokun. precious@ [adelekeuniversity.edu.ng](adelekeuniversity.edu.ng)[ ](adelekeuniversity.edu.ng)RECEIVED 16 March 2026 REVISED 21 May 2026 ACCEPTED 25 May 2026 PUBLISHED 23 June 2026  \nCITATION  \nFabrael FB, Sotunsa J, Olaniyi KS, Oghenetega OB, Adewale O, Akindele BM, Olanrewaju F, Gbimadee NL, Olayemi S, Bolaji AO, Iyobhebhe MO, Adegbotoluwa EM, Folahanmi ED, Kaisar JA and Oyedokun PA (2026) Impact of plant-based interventions on gynecological cancers: a narrative review  \nof mechanistic interplays and clinical evidence.  \nFront. Mol. Med. 6:1832188 .  \ndoi: 10.3389/fmmed.2026.1832188  \nCOPYRIGHT  \n© 2026 Fabrael, Sotunsa, Olaniyi, Oghenetega, Adewale, Akindele, Olanrewaju, Gbimadee, Olayemi, Bolaji, Iyobhebhe, Adegbotoluwa, Folahanmi, Kaisar and Oyedokun. This is an openaccess article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nImpact of plant-based interventions on gynecological cancers: a narrative review of mechanistic interplays and clinical evidence  \nFidelis Batale Fabrael 1,2, John Sotunsa 3, Kehinde Samuel Olaniyi 4,  \nOnome Bright Oghenetega 5, Oluwatobi Adewale 6,7, Blessing Monica Akindele 2,8, Faith Olanrewaju 5, Nekabari Lekpa Gbimadee 5, Seyi Olayemi 5,  \nAbosede Oreoluwa Bolaji 5, Marvellous Osewe Iyobhebhe 9, Emmanuel Mololuwa Adegbotoluwa 5,  \nEmmanuel Damilare Folahanmi 9, John Ahmadu Kaisar 1 and Precious Adeoye Oyedokun 5,7*  \n1Department of Biochemistry, Ahmadu Bello University, Zaria, Kaduna, Nigeria, 2Reproductive Biology and Toxicology Research Laboratory, Oasis of Grace Hospital, Osogbo, Osun, Nigeria, 3Department of Obstetrics and Gynecology, Benjamin Carson (SNR) College of Health and Medical Sciences, Babcock University, Ilisha Remo, Ogun, Nigeria, 4Department of Physiology, Afe Babalola University, Ado-Ekiti, Nigeria, 5Department of Physiology, Adeleke University, Ede, Osun, Nigeria, 6Department of Biochemistry, Ladoke Akintola University of Technology, Ogbomoso, Oyo, Nigeria, 7Axon Plus Research Consortium, Ogbomoso, Oyo, Nigeria, 8Department of Physiology, Ladoke Akintola University of Technology, Ogbomoso, Oyo, Nigeria, 9Department of Anatomy, Adeleke University, Ede, Osun, Nigeria  \nGynecological cancers account for approximately 1.4 million new cases and 680,000 deaths annually. Cervical, ovarian, endometrial, vulvar, and vaginal cancers collectively impose a major and disproportionate burden on women in low- and middle-income countries. Conventional treatments, including surgery, platinum-based chemotherapy, and radiotherapy, are limited by systemic toxicity, acquired chemoresistance, recurrence, and financial inaccessibility in resource-limited settings. Approximately 80 percent of patients with advanced ovarian cancer eventually develop platinum resistance, and cervical cancer persists as a leading cause of cancer death in regions withinadequate screening and vaccination infrastructure. Plant-derived phytochemicals have attracted substantial scientific attention as adjunct or complementary anticancer strategies. This review synthesizes preclinical, epidemiological, and emerging clinical evidence for alkaloids, flavonoids, terpenoids, polyphenols, coumarins, and organosulfur compou","cbCaiePBwz4sEim7","https://ap.wps.com/l/cbCaiePBwz4sEim7","pdf",3156760,"English","# Introduction\n# Mechanistic Interplays of Phytochemicals\n## Modulation of Oncogenic Pathways\n# Clinical Evidence and Translational Challenges\n## Bioavailability and Standardization\n# Nanoformulation Strategies and Future Directions","[{\"question\":\"What major problems limit current treatment of gynecological cancers?\",\"answer\":\"Surgery, platinum-based chemotherapy, and radiotherapy are constrained by systemic toxicity, acquired chemoresistance, recurrence, and poor financial accessibility in resource-limited settings. The review also notes persistent cervical cancer linked to insufficient screening and vaccination infrastructure.\"},{\"question\":\"Which plant-derived compound classes are covered and what mechanisms do they affect?\",\"answer\":\"The review synthesizes evidence for alkaloids, flavonoids, terpenoids, polyphenols, coumarins, and organosulfur compounds. These modulate tumor proliferation, apoptosis (intrinsic and extrinsic), angiogenesis, oxidative stress, inflammation, hormone receptor signaling, HPV E6/E7 oncoprotein expression, and epigenetic regulation.\"},{\"question\":\"Why is clinical translation difficult for most phytochemicals, and how might nanoformulations help?\",\"answer\":\"Most non-approved phytochemicals face poor oral bioavailability, unstandardized botanical preparations, limited randomized trial data, and incompletely characterized herb-drug interaction profiles. Nanoformulation approaches such as liposomal encapsulation, PLGA nanoparticles, and phytosomes are discussed as practical routes to overcome pharmacokinetic obstacles.\"}]","Impact of plant-based interventions on gynecological cancers - narrative review of mechanistic interplays and clinical evidence | PDF",1790110694,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2d088c21050963d33052c42a8204d3d1.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0d06ca882b1200f682d30c90277eb6e5.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d51fafc63e802f1b27520abaedc5dd61.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fa70153c797dfb41c5a2eb92d02e98f8.webp",980,1385]